Dapagliflozin 10mg Tab

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

Dapagliflozin in Living-Donor Kidney Transplant Recipients

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

The Fontan Dapagliflozin Pilot Study

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

SGLT2i, Pioglitazone, and Ketone Production in T1D

PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

The Effect of Dapagliflozin on Myocardial Strain in Patients With Acute Heart Failure

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

Dapagliflozin in STEMI